NasdaqCM - Nasdaq Real Time Price USD

Axogen, Inc. (AXGN)

11.83
+0.05
+(0.42%)
At close: May 16 at 4:00:01 PM EDT
11.71
-0.12
(-1.01%)
Pre-Market: 7:12:23 AM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 48.56M
Earnings -925k

Q2'24

Q3'24

Q4'24

Q1'25

0
10M
20M
30M
40M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

21.00
24.43 Average
11.83 Current
30.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 5555
Avg. Estimate 0.060.060.20.47
Low Estimate 0.040.050.160.39
High Estimate 0.070.090.270.73
Year Ago EPS 0.050.070.130.2

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 7777
Avg. Estimate 53.16M56.13M216.64M251.56M
Low Estimate 52.7M55.7M215.5M247.8M
High Estimate 54.1M56.5M219M259.2M
Year Ago Sales 47.91M48.64M187.34M216.64M
Sales Growth (year/est) 10.96%15.38%15.64%16.12%

Earnings History

Currency in USD 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. -0.040.010.040.02
EPS Actual 0.050.070.07-0.02
Difference 0.090.060.03-0.04
Surprise % 219.05%366.67%94.44%-225.00%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.060.060.20.47
7 Days Ago 0.080.080.280.51
30 Days Ago 0.080.080.280.51
60 Days Ago 0.080.080.280.51
90 Days Ago 0.070.090.310.49

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --1----
Up Last 30 Days ----1--
Down Last 7 Days 1--11
Down Last 30 Days 11--1

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
AXGN 16.00%-8.57%56.92%132.35%
S&P 500 13.31%2.67%7.78%13.74%

Upgrades & Downgrades

Maintains Canaccord Genuity: Buy to Buy 5/13/2025
Initiated Lake Street: Buy 3/17/2025
Reiterates Cantor Fitzgerald: Overweight to Overweight 3/5/2025
Reiterates Citizens Capital Markets: Market Outperform to Market Outperform 3/5/2025
Maintains Canaccord Genuity: Buy to Buy 2/26/2025
Maintains Citizens Capital Markets: Market Outperform to Market Outperform 2/26/2025

Related Tickers